IBD Weekly Top Ranked Medical Stocks
From BioHealth Investor
From BioHealth Investor
by H.S. AyoubBioHealthInvestor.com
by H.S. AyoubBioHealth Investor.com Biotechnology GENETIC TECH SPON +48.22% DENDREON CORP +19.69% CORCEPT THERAPEUTICS +15.70% ANTIGENICS INC +14.83% REXAHN PHARMACEUTICL +14.29% Diagnostic Substances BIOSITE INC +10.45% HEALTHCARE TECH LTD +9.46% IMMUCOR INC +9.15% SYNOVICS…
by H.S. AyoubBioHealth Investor.com Biotechnology IDM PHARMA INC +45.33% NANOGEN INC +30.95% ENCYSIVE PHARMA +14.89% CARDIOVASCULAR BIOTH +12.80% CYTRX CP +12.69% Diagnostic Substances HEALTHCARE TECH LTD +17.46% ASPENBIO PHARMA INC +8.24% PRESSURE BIOSCIENC +7.37%…
Cramer in a question from a student tonight on CNBC’s MAD MONEY was actually asked about the recently wild Dendreon (DNDN-NASDAQ). What he said was that he thinks it can still go up and…
Stock Tickers: MEDX, DNDN When traders made bets and saw a move of more than 200% at one point onFriday in Dendreon (DNDN), this is the sort of news that can getbiotechs with upcoming…
by H.S. AyoubBioHealth Investor.com
ICAgen’s (ICGN-NASDAQ) stock is being crushed in after-hours trading, although the trading volume is very light. Shares are down 37% to $1.15 after closing down 2.6% today. Read on, because this one sounds in…
by H.S. AyoubBioHealth Investor.com Biotechnology STEMCELLS INC +18.25% NOVAVAX INC +17.76% POLYMEDIX INC +15.79% IDM PHARMA INC +15.15% AASTROM BIOSCIENCE +13.77% Diagnostic Substances ICAGEN, INC. +17.39% REMOTEMDX INC +6.54% EPICEPT CORPORATION +5.20% AMER BIO…
by H.S. AyoubBioHealth Investor Scientists in Britain announced that a new heart-like muscle mass, complete with blood vessels and various types of cells, was grown from stem cells harvested from bone marrow. The lead…
by H.S. AyoubBioHealth Investor.com The following articles were the most popular at BioHealth Investor for the week of March 24 – March 30.
Stock Tickers: WYE, NRMX, ELN, NVS, PFE, LLY, JNJ, AZN, TRGT, SNH, SRZ, BKD, ALC, HCR, ESC, MYGN, FRX, NYMX, ICGN, MEMY, EPIX, SI, ESALY, MRK, MATK This weekend, Barron’s has run its cover…
This shouldn’t be any shocker now, but the small-cap biotech stocks are getting attention this morning. Of particular interest are the ones with clinical development programs for prostate and other cancers. When you get…
Dendreon (DNDN-NASDAQ) won big yesterday after receiving panel backing from the FDA for Provenge for the treatment of advanced prostate cancer. The stock has reopened for trading just a few minutes ago and the…
By Chad Brand of Peridot Capitalist LOS ANGELES, March 26 (Reuters) – Shares of Alexion Pharmaceuticals Inc. (ALXN) rose more than 9 percent on Monday after the company told analysts that its treatment for…